Board Meeting30 May 2026, 04:01 pm
Ishita Drugs Approves Audited Financial Results for FY26
AI Summary
Ishita Drugs & Industries Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, along with the Directors' Report, Corporate Governance report, Management Discussion and Analysis Report, and notice for the 33rd Annual General Meeting. The board also approved the re-appointment of Internal Auditors for the year 2026-27 and took on record the Disclosure of Interest of Directors.
Key Highlights
- Audited financial results for the quarter and year ended March 31, 2026, approved.
- Directors' Report, Corporate Governance report, and AGM notice approved.
- Internal Auditors re-appointed for the year 2026-27.
- Disclosure of Interest of Directors taken on record.
Price Impact
More from ISHITADR